PORTALAC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Portalac, and when can generic versions of Portalac launch?
Portalac is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in PORTALAC is lactulose. There is one drug master file entry for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the lactulose profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Portalac
A generic version of PORTALAC was approved as lactulose by PHARM ASSOC on July 30th, 1996.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PORTALAC?
- What are the global sales for PORTALAC?
- What is Average Wholesale Price for PORTALAC?
Summary for PORTALAC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 40 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,894 |
| DailyMed Link: | PORTALAC at DailyMed |
Recent Clinical Trials for PORTALAC
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tampa General Hospital | Phase 4 |
US Patents and Regulatory Information for PORTALAC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | PORTALAC | lactulose | SOLUTION;ORAL, RECTAL | 072374-001 | Mar 22, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
